A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis.

MLA

Shaw, Peter, et al. “A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis.” Genes, vol. 13, no. 3, Mar. 2022. EBSCOhost, https://doi.org/10.3390/genes13030463.

APA

Shaw, P., Senthilnathan, R., Sankar, S., Ilangovan, I., Kodiveri Muthukaliannan, G., Baxi, S., Mani, R. R., Rajagopal, M., Chinnappan, S., Balaraman, A. K., Suresh, D., Krishnan, S., Gupta, M., Muthusamy, T., Paranjothy, C., & Jayaraj, R. (2022). A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis. Genes, 13(3). https://doi.org/10.3390/genes13030463

Chicago

Shaw, Peter, Raghul Senthilnathan, Srivarshini Sankar, Ilamathi Ilangovan, Gothandam Kodiveri Muthukaliannan, Siddhartha Baxi, Ravishankar Ram Mani, et al. 2022. “A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis.” Genes 13 (3). doi:10.3390/genes13030463.